PLAB Stock Analysis: Photronics | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 1.702m USD | 12M Return: 41.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 47.8M
EPS Trend: 17.8%
Qual. Beats: -1
Rev. Trend: -79.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Photronics, Inc. (NASDAQ: PLAB) is a U.S.-based manufacturer and seller of photomask products and services, operating across the United States, Taiwan, China, Korea, Europe, and other international markets. Founded in 1969 and headquartered in Brookfield, Connecticut, the company supplies photomasks used to transfer circuit patterns onto semiconductor wafers and flat panel display (FPD) substrates during the fabrication of integrated circuits and displays. It also offers related electrical and optical components, serving semiconductor and FPD designers, manufacturers, and foundries through its direct sales force.
Operating within the Semiconductor Materials & Equipment sub-industry, Photronics occupies a specialized niche in the chip and display supply chain, as photomasks function as precision stencils that define circuit patterns in lithography processes. The companys significant Asian footprint reflects the regional concentration of leading foundries and display panel producers, which are key end customers for photomask suppliers.
- Leading-edge node demand boosts photomask revenue
- Taiwan and Korea foundry orders drive Asia segment growth
- Flat panel display weakness pressures FPD margins
| Net Income: 159.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.30 > 1.0 |
| NWC/Revenue: 87.90% < 20% (prev 80.42%; Δ 7.48% < -1%) |
| CFO/TA 0.15 > 3% & CFO 282.2m > Net Income 159.1m |
| Net Debt (-633.8m) to EBITDA (320.1m): -1.98 < 3 |
| Current Ratio: 5.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.6m) vs 12m ago -3.95% < -2% |
| Gross Margin: 33.77% > 18% (prev 36.29%; Δ -2.51% > 0.5%) |
| Asset Turnover: 47.40% > 50% (prev 50.31%; Δ -2.91% > 0%) |
| Interest Coverage Ratio: 4.34k > 6 (EBIT TTM 243.1m / Interest Expense TTM 56.0k) |
| A: 0.39 (Total Current Assets 943.9m - Total Current Liabilities 187.0m) / Total Assets 1.93b |
| B: 0.44 (Retained Earnings 845.8m / Total Assets 1.93b) |
| C: 0.13 (EBIT TTM 243.1m / Avg Total Assets 1.82b) |
| D: 5.23 (Book Value of Equity 1.24b / Total Liabilities 237.4m) |
| Altman-Z'' = 10.39 = AAA |
| DSRI: 0.96 (Receivables 189.0m/196.0m, Revenue 861.2m/856.7m) |
| GMI: 1.07 (GM 36.29% / 33.77%) |
| AQI: 1.31 (AQ_t 0.03 / AQ_t-1 0.02) |
| SGI: 1.01 (Revenue 861.2m / 856.7m) |
| TATA: -0.06 (NI 159.1m - CFO 282.2m) / TA 1.93b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 28.14 with a total of 1,201,976 shares traded. Over the past week, the price has changed by -13.50%, over one month by -6.07%, over three months by -35.00% and over the past year by +41.48%.
Current recommended Stop Loss: 25.20 (which is 10.4% or 1.2 ATR below the current price).
Photronics has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy PLAB.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42.3 | 50.4% |
P/E Trailing = 10.6494
P/E Forward = 13.2626
P/S = 1.976
P/B = 1.4403
P/EG = 2.6419
Revenue TTM = 861.2m USD
EBIT TTM = 243.1m USD
EBITDA TTM = 320.1m USD
Long Term Debt = 10.0k USD (from longTermDebt, two quarters ago)
Short Term Debt = 11.0k USD (from shortTermDebt, last quarter)
Debt = 3.86m USD (from shortLongTermDebtTotal, last quarter) (leases 3.86m already included)
Net Debt = -633.8m USD (calculated: Debt 3.86m - CCE 637.7m)
Enterprise Value = 1.07b USD (1.70b + Debt 3.86m - CCE 637.7m)
Interest Coverage Ratio = 4.34k (Ebit TTM 243.1m / Interest Expense TTM 56.0k)
EV/FCF = 11.10x (Enterprise Value 1.07b / FCF TTM 96.2m)
FCF Yield = 9.01% (FCF TTM 96.2m / Enterprise Value 1.07b)
FCF Margin = 11.18% (FCF TTM 96.2m / Revenue TTM 861.2m)
Net Margin = 18.47% (Net Income TTM 159.1m / Revenue TTM 861.2m)
Gross Margin = 33.77% ((Revenue TTM 861.2m - Cost of Revenue TTM 570.3m) / Revenue TTM)
Gross Margin QoQ = 31.32% (prev 34.97%)
Tobins Q-Ratio = 0.55 (Enterprise Value 1.07b / Total Assets 1.93b)
Interest Expense / Debt = 1.45% (Interest Expense 56.0k / Debt 3.86m)
Taxrate = 13.12% (31.9m / 243.1m)
NOPAT = 211.2m (EBIT 243.1m * (1 - 13.12%))
Current Ratio = 5.05 (Total Current Assets 943.9m / Total Current Liabilities 187.0m)
Debt / Equity = 0.00 (Debt 3.86m / totalStockholderEquity, last quarter 1.24b)
Debt / EBITDA = -1.98 (Net Debt -633.8m / EBITDA 320.1m)
Debt / FCF = -6.59 (Net Debt -633.8m / FCF TTM 96.2m)
Total Stockholder Equity = 1.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.75% (Net Income 159.1m / Total Assets 1.93b)
RoE = 13.39% (Net Income TTM 159.1m / Total Stockholder Equity 1.19b)
RoCE = 20.46% (EBIT 243.1m / Capital Employed (Equity 1.19b + L.T.Debt 10.0k))
RoIC = 12.42% (NOPAT 211.2m / Invested Capital 1.70b)
WACC = 13.22% (E(1.70b)/V(1.71b) * Re(13.25%) + D(3.86m)/V(1.71b) * Rd(1.45%) * (1-Tc(0.13)))
Discount Rate = 13.25% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -58.04 | Cagr: -2.18%
[DCF] Terminal Value 61.56% ; FCFF base≈93.7m ; Y1≈99.6m ; Y5≈118.0m
[DCF] Fair Price = 27.44 (EV 984.4m - Net Debt -633.8m = Equity 1.62b / Shares 59.0m; r=13.22% [WACC]; 5y FCF grow 6.95% → 2.50% )
EPS Correlation: 17.76 | EPS CAGR: 0.95% | SUE: -1.19 | # QB: -1
Revenue Correlation: -79.79 | Revenue CAGR: -1.51% | SUE: -0.65 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.40 | Chg30d=+2.10% | Revisions=-40% | Analysts=3
EPS current Year (2026-10-31): EPS=1.86 | Chg30d=+0.81% | Revisions=-40% | GrowthEPS=-7.5% | GrowthRev=+1.2%
EPS next Year (2027-10-31): EPS=2.02 | Chg30d=-0.25% | Revisions=-40% | GrowthEPS=+8.6% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: -67% (up=0, down=6)